RESEARCH NOTICE & LEGAL DISCLAIMER

FOR RESEARCH PURPOSES ONLY. All information provided within the Biolabs Peptides Research Centre is intended strictly for scientific, laboratory, and educational purposes.

Not Medical Advice: The protocols and data presented herein do not constitute medical advice, nursing advice, or a professional healthcare diagnosis.
Non-Therapeutic: These peptides are not intended to diagnose, treat, cure, or prevent any medical condition or disease.
Researcher Responsibility: Any research conducted should be performed by qualified professionals in a controlled laboratory environment. By accessing this data, you acknowledge that you are responsible for following your local laws and institutional safety guidelines.

GHK-Cu (100mg)

SHOP VIALS

SHOP PRE-FILLED PEN

HIGHLIGHTS

GHK-Cu (Copper Peptide) is a powerful "signal peptide" studied for its ability to reset human genes to a more youthful, regenerative state. In a 100mg vial format, it offers a high-capacity option for researchers studying long-term tissue repair, skin remodeling, and anti-inflammatory signaling. This Biolabs Peptides guide provides a graduated research framework to observe the cumulative biological effects of copper-binding tripeptides.

Observed Benefits

Gene Phenotype Reversal: Observed in studies to modulate over 30% of human genes toward a regenerative phenotype.
Deep Dermal Repair: Promotes increased skin thickness and density by stimulating collagen and elastin.
Systemic Anti-Inflammation: Suppresses pro-inflammatory cytokines like TNF-α and IL-6 in research models.
Enhanced Blood Flow: Supports angiogenesis (new blood vessel formation) to improve nutrient delivery to tissues.
Antioxidant Defense: Activates protective enzymes to shield cells from oxidative damage and aging.

Protocol Overview

Research involving GHK-Cu typically utilizes subcutaneous administration. Because the 100mg vial is highly concentrated, it is best reconstituted with 3.0 mL of Bacteriostatic Water. This creates a potent concentration of approximately 33.3 mg per mL. Studies often follow a "5 days on, 2 days off" schedule for 12 weeks to allow for steady observation of tissue improvements.

Research Protocol Dosing

Initial Phase (Weeks 1–4): 1.0 mg (3 units on a U-100 syringe) — Inject 5 days per week.

Intermediate Phase (Weeks 5–8): 1.5 mg (4.5 units on a U-100 syringe) — Inject 5 days per week.

Target Phase (Weeks 9–12): 2.0 mg (6 units on a U-100 syringe) — Inject 5 days per week.

Alternative Simplified Schedule: 2.0 mg (6 units on a U-100 syringe) — Inject 3 days per week (e.g., Mon/Wed/Fri).

Supplies Needed

Biolabs Peptides GHK-Cu: 100mg Lyophilized Vial.
Reconstitution Liquid: 3.0 mL of Bacteriostatic Water.
Syringes: U-100 Precision Insulin Syringes (30-unit or 50-unit syringes recommended for low volumes).
Prep: Alcohol swabs for sterilization of the vial stopper and research site.

Storage

Pre-reconstitution (Lyophilized Powder): Store in a freezer at -20°C (-4°F) for long-term stability (12+ months). Keep away from light and moisture.
Post-reconstitution (Liquid Solution): Must be refrigerated at 2–8°C (36–46°F). For optimal research integrity, the solution should be used within 30 days. The solution will naturally appear blue due to the copper content; discard if it becomes cloudy.